(S)-2-(4-Acetoxyphenyl)-4-oxochromane-5,7-diyl diacetate

Catalog No. :
ACGHYD861
CAS No. :
3682-04-0
Molecular Formula :
C21H18O8
Molecular Weight :
398.37

IUPAC Name:(S)-2-(4-acetoxyphenyl)-4-oxochromane-5,7-diyl diacetate

(S)-2-(4-Acetoxyphenyl)-4-oxochromane-5,7-diyl diacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$417.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(4-Acetoxyphenyl)-4-oxochromane-5,7-diyl diacetate
IUPAC Name(S)-2-(4-acetoxyphenyl)-4-oxochromane-5,7-diyl diacetate
MDL No.MFCD00706050
Molecular FormulaC21H18O8
Molecular Weight398.37
SMILESO(C(C)=O)C1=C2C(O[C@@H](CC2=O)C3=CC=C(OC(C)=O)C=C3)=CC(OC(C)=O)=C1
InChI KeyHQZXCNZZVRAEPO-SFHVURJKSA-N
Synonym[4-(5,7-diacetyloxy-4-oxo-2,3-dihydrochromen-2-yl)phenyl] acetate | DTXSID50559290 | HQZXCNZZVRAEPO-UHFFFAOYSA-N | AKOS022184613 | 2-[4-(Acetyloxy)phenyl]-4-oxo-3,4-dihydro-2H-1-benzopyran-5,7-diyl diacetate | 4',5,7-Triacetoxyflavanone | Naringenin triac
CAS No.3682-04-0
PubChem CID14354984

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGHYD861 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHYD861 route product structure diagram
    ACGHYD8613682-04-0
Inquiry

2. ACGHYD861 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHYD861 route product structure diagram
    ACGHYD8613682-04-0
Inquiry

Comments (0)